In this retrospective study the outcome of 324 patients with low-grade
gliomas (WHO-Grade II) is evaluated, who from 1979 to 1991 underwent
stereotactic biopsy and interstitial radiosurgery (Iodine-125). The pa
tients were selected for interstitial radiosurgery if the tumor was un
ifocal, well-circumscribed and in diameter less-than-or-equal-to 4 cm.
Of these patients 251 had astrocytomas. 29 had oligodendrogliomas, an
d 44 had oligoastrocytomas. All patients presented with progressive ne
urological deficit or showed evidence of CT/MRI confirmed tumor growth
. The preoperative performance status was greater-than-or-equal-to 70%
. Diffusely infiltrative, non-delineated gliomas and gliomas crossing
the midline were excluded. Five-year survival rates were 65% for astro
cytomas, 80% for oligoastrocytomas and 58% for oligodendrogliomas. In
the multivariate analysis age was a significant factor predicting surv
ival. Patients who received temporary implants had a significantly bet
ter outcome than those with permanent implants. Radiation toxicity (3.
1%) was seen mostly among the permanent implants. No patients required
reoperation due to radionecrosis. The findings in this subgroup of gl
iomas indicate that interstitial radiosurgery using Iodine-125 is effe
ctive in controlling tumor growth and is well tolerated. Patients with
differentiated and circumscribed gliomas particularly benefit from th
e treatment.